TBRG
NEUTRALAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Stock trades at a significant premium to defensive fair value, relying entirely on future growth projections.
- Low PEG ratio
- Price far exceeds Graham Number ($8.94)
- High trailing P/E
Future outlook is bullish based on earnings trajectory, though revenue stagnation is a concern.
- Strong Forward P/E
- Massive YoY EPS growth (+1480%)
- Positive earnings surprise trend
- Flat YoY revenue growth
Long-term performance has been poor, but short-term momentum is shifting.
- Recent 1-month price surge (+51.5%)
- Negative 5Y and 3Y price performance
- Historical earnings volatility
Strong balance sheet and operational efficiency improvements.
- Piotroski F-Score 7/9
- Current Ratio 1.80
- Quick Ratio 1.42
- Low ROE (2.52%)
Non-dividend paying growth/turnaround stock.
- No dividend payments
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for TBRG and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
TBRG
TruBridge, Inc.
Primary
|
-22.7% | -18.7% | -3.7% | +17.2% | +51.5% | +9.2% |
|
TOI
The Oncology Institute, Inc.
Peer
|
-65.3% | +535.4% | +47.3% | -17.0% | +6.0% | +6.7% |
|
LAB
Standard BioTools Inc.
Peer
|
-80.7% | -51.6% | -19.1% | -30.5% | -8.2% | -2.2% |
|
KROS
Keros Therapeutics, Inc.
Peer
|
-80.9% | -70.2% | -8.5% | -28.6% | -0.6% | -6.6% |
|
SIGA
SIGA Technologies, Inc.
Peer
|
+2.3% | +19.3% | -0.8% | -35.2% | +10.7% | +9.2% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Quarterly Earnings History
EPS performance vs analyst estimates
Healthcare Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
TBRG
TruBridge, Inc.
|
NEUTRAL | $347.91M | 79.93 | 2.5% | 1.3% | $23.18 | |
|
TOI
The Oncology Institute, Inc.
|
BEARISH | $347.91M | - | -% | -12.1% | $3.52 | Compare |
|
LAB
Standard BioTools Inc.
|
BEARISH | $345.33M | - | -13.1% | -87.8% | $0.89 | Compare |
|
KROS
Keros Therapeutics, Inc.
|
NEUTRAL | $341.37M | 4.87 | 19.9% | 35.7% | $11.21 | Compare |
|
SIGA
SIGA Technologies, Inc.
|
BEARISH | $341.03M | 14.88 | 11.2% | 24.6% | $4.76 | Compare |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-08 | FOWLER CHRISTOPHER L. | Chief Executive Officer | Stock Award | 19,683 | - |
| 2026-04-08 | PLESSNER KEVIN | General Counsel | Stock Award | 2,598 | - |
| 2026-04-08 | BASSI VINAY | Chief Financial Officer | Stock Award | 12,698 | - |
| 2026-04-08 | MACINTYRE VITA | Officer | Stock Award | 909 | - |
| 2026-04-08 | WILSON MERIDETH | Officer | Stock Award | 5,206 | - |
| 2026-04-08 | HARSE DAVID | Officer | Stock Award | 5,079 | - |
| 2026-04-08 | DAUGHTON MICHAEL E | Officer | Stock Award | 10,572 | - |
| 2025-12-03 | PINETREE CAPITAL LTD | Beneficial Owner of more than 10% of a Class of Security | Purchase | 130,000 | $2,932,400 |
| 2025-11-19 | PINETREE CAPITAL LTD | Beneficial Owner of more than 10% of a Class of Security | Purchase | 32,847 | $674,644 |
| 2025-11-19 | PINETREE CAPITAL LTD | Beneficial Owner of more than 10% of a Class of Security | Purchase | 37,847 | $777,244 |
| 2025-11-17 | DAUGHTON MICHAEL E | Officer | Purchase | 50,000 | $999,171 |
| 2025-11-14 | PINETREE CAPITAL LTD | Beneficial Owner of more than 10% of a Class of Security | Purchase | 48,903 | $990,503 |
SEC Filings
Recent regulatory filings from the SEC EDGAR database
TruBridge, Inc. has pivoted its strategic focus toward revenue cycle management (RCM), which represented 64% of consolidated revenue in 2025. While the company serves over 1,500 healthcare organizations, it faces risks from market saturation and consolidation within the acute care hospital sector. Specifically, a narrowing target market of hospitals with fewer than 200 beds may limit new system installations and exert downward pressure on pricing.
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning TBRG from our newsroom.